Adaptive Decision Support for Addiction Treatment (ADAPT) Factorial Trial
NCT06793696 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1129
Last updated 2026-01-27
Summary
This study is stage 1 of a larger study which refines and optimizes the EMBED\* clinical decision support (CDS; see NCT03658642) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
This study does not have open enrollment. Investigators will use a Multiphase Optimization STrategy (MOST) framework study with preparation, optimization, and confirmatory phases. In the current project, optimization phase, stage1 investigators will conduct a 2x2x2 factorial trial in which they expand EMBED to include sustainable implementation strategies: nurse prompt for withdrawal assessment, and targeted clinician prompt to use the CDS along with patient resources to promote equity and motivate readiness to start treatment.
Later study phases will include optimization phase, stage 2: rapid-cycle randomized testing, and evaluation phase: a randomized trial of the optimized package compared to the original EMBED and the evaluation phase in which investigators will compare the efficacy of the optimized, multicomponent CDS package to the original EMBED CDS on ED-initiation of buprenorphine rates in patients with OUD in a randomized trial.
\*EMBED is a user centered, clinician facing clinical decision support system integrated into the electronic health record workflow to facilitate initiating buprenorphine in the emergency department by: diagnosing opioid use disorder with a checklist based on the diagnostic criteria of the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition), assessing the severity of withdrawal with the Clinical Opioid Withdrawal Scale (COWS), motivating patients to accept treatment with a scripted brief negotiation interview, and automating the electronic health record workflow, including clinical and after visit documentation, order entry, prescribing, and referral for ongoing treatment in the community
Conditions
- Opioid Use Disorder
- Clinical Decision Support
Interventions
- OTHER
-
Nurse prompt
Nurse prompt to complete COWS
- OTHER
-
Provider prompt
Provider prompt to use EMBED CDS
- OTHER
-
Patient facing materials
Patient materials provided at discharge from ED
- OTHER
-
EMBED
Original EMBED CDS
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Edward Melnick, MD, MHS · Yale University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-21
- Primary Completion
- 2025-10-14
- Completion
- 2025-10-14
Countries
- United States
Study Locations
More Related Trials
-
Opioid Use Disorder in the Emergency Department: CTN 0069
NCT03023930 ·Status: COMPLETED ·Phase: NA
-
Usability Testing for the Reward-based Technology to Improve OUD Treatment
NCT05159362 ·Status: COMPLETED ·Phase: NA
-
Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients
NCT04650386 ·Status: COMPLETED ·Phase: NA
-
Contingency Management to Enhance Office-Based Buprenorphine Treatment
NCT04024059 ·Status: COMPLETED ·Phase: NA
-
Emergency Department-Initiated Buprenorphine Validation Network Trial
NCT04225598 ·Status: COMPLETED ·Phase: PHASE2
-
Standard Versus High Dose ED-Initiated Buprenorphine Induction
NCT06494904 ·Status: RECRUITING ·Phase: PHASE3
-
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
NCT06323824 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of RME on Engagement in Buprenorphine Treatment
NCT05184907 ·Status: COMPLETED ·Phase: NA
-
CBT4CBT for Office Based Buprenorphine
NCT03580902 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
NCT00634803 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Improving Office Based Treatment of Opioid Use Disorder With Technology
NCT03586466 ·Status: UNKNOWN ·Phase: NA
-
Buprenorphine Treatment Engagement and Overdose Prevention
NCT03677986 ·Status: COMPLETED ·Phase: NA
-
Patient Decision Aid for Opioid Use Disorder
NCT03568552 ·Status: COMPLETED ·Phase: NA
-
Incentives to Decrease Opioid Use - Pilot
NCT04235582 ·Status: COMPLETED ·Phase: NA
-
Connection, Navigation, Engagement in Care and Treatment for Opioid Use Disorder
NCT04797962 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
NCT00000230 ·Status: COMPLETED ·Phase: PHASE2
-
Distress Tolerance and Buprenorphine
NCT01556087 ·Status: COMPLETED ·Phase: PHASE3
-
A Stepped-Wedge Cluster Randomized Trial of a Digital App to Support Medication-Assisted Treatment in Individuals With Opioid Use Disorder
NCT07140926 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance
NCT00622596 ·Status: COMPLETED ·Phase: NA
-
Emergency Department Outcomes for Patients With Opioid Use Disorder
NCT04289363 ·Status: COMPLETED
-
Clinical Decision Support to Implement ED-initiated Buprenorphine for OUD
NCT03658642 ·Status: COMPLETED ·Phase: NA
-
Patient Reported Outcomes for Opioid Use Disorder
NCT03985163 ·Status: COMPLETED
-
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
NCT06827288 ·Status: RECRUITING ·Phase: NA
-
Buprenorphine Integration Research and Community Health
NCT05668780 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR
NCT03559179 ·Status: COMPLETED ·Phase: NA